Aim: This study aims to assess how diabetes influences the prognosis, success, and complications of dental implants, with the goal of developing effective management strategies for diabetic patients. Materials and methods: The study enrolled a total of 50 patients, aged between 30 and 60 years, including 25 men and 25 women. A total of 80 dental implants were placed, with each patient undergoing a thorough medical history assessment and laboratory investigations, including HbA1c level evaluations. The findings revealed a correlation between HbA1c levels and the incidence of complications relative to the number of implants placed. To ensure accurate statistical evaluation, data analysis was conducted using SPSS software. Results: The percentage of implant failure was 16.67% in the 8.0-8.9 HbA1c group, 5.00% in the 9.0-9.9 group, 16.67% in the 10.0-10.9 group, 9.09% in the 11.0-11.9 group, 6.67% in the 12.0-12.9 group, and 0% in the 13.0-14.0 group. The overall implant failure rate was 10.00%. Peri-implantitis was observed in 36% of patients and affected 33.33% of implants. Peri-implant mucositis occurred in 28% of patients and was present in 25.71% of implants. Mucosal recession was recorded in 20% of patients, affecting 22.85% of implants. Crestal bone loss was the least common complication, occurring in 16% of patients and impacting 17.14% of implants. Conclusion: In conclusion, implant failure rates in diabetic patients are impacted by HbA1c levels, with higher failure rates seen in those with poor glycemic control. While prior studies demonstrate high success rates in well-managed diabetics, our findings emphasize the importance of thorough patient evaluation and individualized treatment strategies to improve implant success.